T1	Participants 767 880	Patients with septic shock who were enrolled in the placebo limb of the North American Sepsis Trial (NORASEPT II)
T2	Participants 998 1030	Nine hundred and thirty patients
T3	Participants 1341 1548	population was broken down into five age groups as follows: less than 50 years (group one), 50 to 64 years (group two), 65 to 74 years (group three), 75 to 84 years (group four), and 85 or older (group five)
T4	Participants 1642 1678	Data were available for 930 patients
T5	Participants 1763 1867	280 patients in group one, 242 in group two, 210 in group three, 150 in group four, and 48 in group five
T6	Participants 2062 2100	oldest group of patients (group five).
